That was one crazy first quarter for the biotech sector. Here's where biotech stocks stand on April Fool's Day:
If you're curious (and I was) about how the biotech ETFs performed during the first quarter of 2014, the (XBI - Get Report) (SPDR S&P Biotech ETF) was up 9.4%, and the (IBB - Get Report) (iShares Nasdaq Biotechnology ETF) rose 4% versus a 1% gain for the (SPY) (SPDR S&P 500 ETF).
No wonder the biotech bubble debate rages on. Watch that downtrend since the middle of March.
Here are the top-performing biotech and drugs stocks in the first quarter:
It says something about the current state of the biotech sector that I only know one of these companies -- Anthera -- well. I've heard a tiny bit about a second, Cormedix. The other three top-performers are total blanks. Bubble on!
Here's a look at the first-quarter performance of the large-cap biotech stocks: